HIS modelling and simulation based cost-benefit analysis of a telemedical system for closed-loop diabetes therapy

International Journal of Medical Informatics

Volumn 76, Issue SUPPL. 3, 2007, Pages

  Bott, Oliver J ^a   Hoffmann, Ina ^a   Bergmann, Joachim ^a   Gusew, Nathalie ^a   Schnell, Oliver ^b   Gómez, Enrique J ^c   Hernando, M Elena ^c   Kosche, Patrick ^a   von Ahn, Christian ^a   Mattfeld, Dirk C ^a   Pretschner, Dietrich P ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^c UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

Author keywords

Cost benefit analysis; Diabetes mellitus; Health information systems; Insulin infusion system; Model; Simulation; Telemedicine

Indexed keywords

COMPUTER SIMULATION; COST BENEFIT ANALYSIS; HEALTH CARE; INFORMATION SYSTEMS; MATHEMATICAL MODELS;

DIABETES MELLITUS; HEALTH INFORMATION SYSTEMS; INSULIN INFUSION SYSTEM;

TELEMEDICINE;

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; COMPUTER INTERFACE; COMPUTER MODEL; COMPUTER SIMULATION; COMPUTER SYSTEM; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST OF ILLNESS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE MODEL; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MEDICAL INFORMATION SYSTEM; PRIORITY JOURNAL; PROBABILITY; TELECONSULTATION; TELEMEDICINE;

COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; HOSPITAL INFORMATION SYSTEMS; HUMANS; INSULIN INFUSION SYSTEMS; MIDDLE AGED; TELEMEDICINE;

EID: 35448941925     PISSN: 13865056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijmedinf.2007.06.002     Document Type: Article

References (38)

1. Bashshur R., Shannon G., and Sapci H. Telemedicine evaluation. Telemed. J. E. Health 11 3 (2005) 296-316
2. Reardon T. Research findings and strategies for assessing telemedicine costs. Telemed. J. E. Health 11 3 (2005) 348-369
3. Hjelmgren J., Berggren F., and Andersson F. Health economic guidelines-similarities, differences and some implications. Value Health 4 3 (2001) 225-250
4. Klose T. A utility-theoretic model for QALYs and willingness to pay. Health Econ. 12 1 (2003) 17-31
5. Gyrd-Hansen D. Willingness to pay for a QALY: theoretical and methodological issues. Pharmacoeconomics 23 5 (2005) 423-432
6. Hailey D. The need for cost-effectiveness studies in telemedicine. J. Telemed. Telecare 11 8 (2005) 379-383
7. Hebert M.A., Korabek B., and Scott R.E. Moving research into practice: a decision framework for integrating home telehealth into chronic illness care. Int. J. Med. Inform. 75 12 (2006) 786-794
8. Roine R., Ohinmaa A., and Hailey D. Assessing telemedicine: a systematic review of the literature. CMAJ 165 6 (2001) 765-771
9. Whitten P.S., Mair F.S., Haycox A., May C.R., Williams T.L., and Hellmich S. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ 324 7351 (2002) 1434-1437
10. Hailey D., Roine R., and Ohinmaa A. Systematic review of evidence for the benefits of telemedicine. J. Telemed. Telecare 8 Suppl. 1 (2002) 1-30
11. Aoki N., Dunn K., Johnson-Throop K.A., and Turley J.P. Outcomes and methods in telemedicine evaluation. Telemed. J. E. Health 9 4 (2003) 393-401
12. Hailey D., Ohinmaa A., and Roine R. Study quality and evidence of benefit in recent assessments of telemedicine. J. Telemed. Telecare 10 6 (2004) 318-324
13. Hailey D., and Jennett P. The need for economic evaluation of telemedicine to evolve: the experience in Alberta, Canada. Telemed. J. E. Health 10 1 (2004) 71-76
14. Farmer A., Gibson O.J., Tarassenko L., and Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet. Med. 22 October (10) (2005) 1372-1378
15. Hernando M.E., Gomez E.J., Gili A., Gomez M., Garcia G., and del Pozo F. New trends in diabetes management: mobile telemedicine closed-loop system. Stud. Health Technol. Inform. 105 (2004) 70-79
16. Larizza C., Bellazzi R., Stefanelli M., Ferrari P., De Cata P., Gazzaruso C., Fratino P., D'Annunzio G., Hernando E., and Gomez EJ. The M2DM project-the experience of two Italian clinical sites with clinical evaluation of a multi-access service for the management of diabetes mellitus patients. Methods Inf. Med. 45 1 (2006) 79-84
17. E.J. Gómez, M.E. Hernando, A. Garcia, F. del Pozo, R. Corcoy, E. Brugués, J. Cermeño, A. de Leiva, Telemedicine as a tool for intensive management of diabetes: the DIABTel experience, in: Comp. Meth. and Prog. in Biomedicine, vol. 69, Elsevier Science Ireland Ltd. (2002) 163-177.
18. Hovorka R., Chassin L.J., and Wilinska M.E. Closing the loop: the Adicol experience. Diab. Technol. Ther. 6 3 (2004) 307-318
19. American Association of Diabetes Educators. Intensive diabetes management: implications of the DCCT and UKPDS. Diab. Educ. 28 September-October (5) (2002) 735-740
20. T. Kaupper, H. Rauch, O. Bott, E. Hernando, I. Hoffmann, E. Standl, D. Pretschner, E. Gomez, O. Schnell, INCA: Mobil- und Internettechnologie zur Sensor-gestützten Insulinpumpentherapie-Ein neuer Weg zur Closed-Loop Applikation (INCA: mobile and internet technology for sensor based insulin therapy-a new way towards closed-loop application, in German), Diabetologie 1 (2006) S23-S172 (Georg Thieme Verlag, KG Stuttgart, New York, ISSN 1861-9002, p. 95).
21. Bott O.J., Bergmann J., Hoffmann I., Vering T., Gomez E.J., Hernando M.E., and Pretschner D.P. The INCA-project: specifying a telemedical system for closed-loop therapy of diabetes using MOSAIK-M. Stud. Health Technol. Inform. 116 (2005) 503-508
22. Wendt T., Häber A., Brigl B., and Winter A. Modeling hospital information systems (part 2): using the 3LGM2 tool for modeling patient record management. Methods Inf. Med. 43 3 (2004) 256-267
23. Girault C., and Valk R. Petri Nets for System Engineering: A Guide to Modeling, Verification, and Applications (2003), Springer, Berlin
24. J. Rumbaugh, I. Jacobson, G. Booch, The Unified Modeling Language Reference Manual, Addison-Wesley, 2004.
25. EBM2000 Plus, 2000, http://www.ebm2000plus.de/ (in German, last accessed on February 14, 2007).
26. Praxis-Leitlinien der Deutschen Diabetes-Gesellschaft (Practice Guidelines of the German Diabetes Association), Diabetes und Stoffwechsel, Suppl. 2, 2002.
27. Davidson J.A. Treatment of the patient with diabetes: importance of maintaining target HbA(1c) levels. Curr. Med. Res. Opin. 20 December (12) (2004) 1919-1927
28. Schlessinger L., and Eddy D.M. Archimedes: a new model for simulating health care systems-the mathematical formulation. J. Biomed. Inform. 35 (2002) 37-50
29. Eddy D.M., and Schlessinger L. Validation of the Archimedes diabetes model. Diab. Care 26 11 (2003) 3102-3110
30. http://www.diabetes.org/diabetesphd/default.jsp (last accessed on January 3, 2006).
31. L. von Ferber, Die direkten Kosten der Komplikationen bei diabetes mellitus (The direct costs of diabetes mellitus related complications), in: Presentation of the 39th Conference of the Deutsche Diabetes Gesellschaft, http://www.pmvforschungsgruppe.de/pdf/03_publikationen/ kodim_lvf_2004.pdf (in German, last accessed on January 3, 2006), 19-22 May 2004 in Hannover (Germany).
32. Scheer A.-W. ARIS-Business Process Modelling. second ed. (1999), Springer, Berlin a.o.
33. Cameron A.E., Bashshur R.L., Halbritter K., Johnson E.M., and Cameron J.W. Simulation methodology for estimating financial effects of telemedicine in West Virginia. Telemed. J. 4 2 (1998) 125-144
34. Moehr J.R., Schaafsma J., Anglin C., Pantazi S.V., Grimm N.A., and Anglin S. Success factors for telehealth-a case study. Int. J. Med. Inform. 75 10-11 (2006) 755-763
35. I. Koster, L. von Ferber, P. Ihle, I. Schubert, H. Hauner, The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM study, Diabetologia 49 (7) (2006) 1498-1504 (Epub May 11 2006).
36. Biermann E. Sparen Prävention und Therapie Folgekosten beim Type-2-Diabetes ein? Computermodelle mit virtuellen Patienten folgen großen Interventionsstudien nach (Does prevention and therapy save follow-up costs in type 2 diabetes? Computer models with virtual patients are succeeding large intervention trials, in German). Diabetologie und Stoffwechsel 1 (2006) 245-251
37. Palmer A.J., Roze S., Valentine W.J., Minshall M.E., Foos V., Lurati F.M., Lammert M., and Spinas G.A. The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr. Med. Res. Opin. 20 Suppl. 1 (August 2004) S5-S26
38. Roze S., Valentine W.J., Zakrzewska K.E., and Palmer A.J. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK. Diab. Med. 22 September (9) (2005) 1239-1245